These compounds may interact with:
Vascular endothelial growth factor receptor 1
Potentially involved in: cardiovascular system disease; lung cancer; breast cancer; melanoma; kidney cancer; carcinoma; skin cancer; hypertension; cancer; proteinuria; diabetic retinopathy; retinopathy of prematurity; age related macular degeneration; keratitis; diabetes mellitus; capillary hemangioma; placental insufficiency; renal cell carcinoma; hemangiosarcoma; liver cirrhosis
Disease data sourced from Pharos.